Filing Flows

Filing Flows › LifeMD (LFMD) › Q1 2025

LifeMD (LFMD) Q1 2025 earnings results (first quarter 2025)

10-Q filed May 6, 2025

LifeMD (LFMD) reported revenue of $65.7M for the first quarter 2025 (Q1 2025), +49% from a year earlier and +4% from the quarter before. Operating margin was 3.9%, net earnings $1.9M (2.9% of revenue).

Revenue$65.7M
Year over year+49%
Quarter over quarter+4%
Operating margin3.9%
Net earnings$1.9M

LifeMD, Q1 2025: revenue $65.7M (+49% year over year), operating margin 3.9%, net earnings $1.9M, operating cash flow $3.1M. The chart follows the revenue to costs, profit and cash.

Q1 2025AmountQ/QY/Y
Revenue$65.7M+4%+49%
Operating profit$2.5M+150%—
Net earnings$1.9M+717%—
Operating cash flow$3.1M+186%-41%
Free cash flow$1.1M+22%-79%

What changed

Revenue was $65.7M in Q1 2025, up 49% year over year and up 4% from the previous quarter.

Gross margin was 86.8%, down 2.7 points from a year earlier. Operating profit was $2.5M, a 3.9% margin (up 17.9 points year over year). Operating expenses grew 19% against revenue growth of 49%. The fastest-growing cost line was Other operating costs (+32%). Net earnings were $1.4M.

Operating cash flow was $3.1M (down 41% year over year), 160% of net income including minority interests. Non-cash charges added back $400K of depreciation and amortization and $2.5M of share-based compensation. Working capital and other items used $1.8M. Capital expenditures of $2.0M left free cash flow of $1.1M.

Questions

What was LifeMD's revenue in the first quarter 2025?

LifeMD (LFMD) reported revenue of $65.7M for the first quarter 2025 (Q1 2025), +49% from a year earlier and +4% from the quarter before.

Was LifeMD profitable in the first quarter 2025?

Operating profit was $2.5M (3.9% of revenue) and net earnings $1.9M.

Open the interactive Sankey →

Source: LifeMD 10-Q on SEC EDGAR.